NASDAQ:RGNX

Regenxbio Stock Insider Trading

etoro logo Buy RGNX
*Your capital is at risk
$6.69
+0.170 (+2.61%)
At Close: Jun 03, 2026

REGENXBIO Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 22.20. In total, the insiders bought 2.7M and sold 468.73K RGNX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
22.20
Buy 2.7M shares
Sell 468.73K shares
70% Buy Activity
Negligible or No Correlation
Buy Signal Medium Confidence
May 29, 2026

Analysis Breakdown:

  • Supported by a positive Insider Power Score of 22.2.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jan 06, 2026
Buy
Stock Options (Right to buy)
A-Award
Christmas Patrick J.
Chief Strategy & Legal Officer
Officer 39 650
Value: $562.2K
Jan 06, 2026
Buy
Common Stock
A-Award
Christmas Patrick J.
Chief Strategy & Legal Officer
Officer 73 749
Value: $1.05M
Jan 06, 2026
Buy
Stock Options (Right to buy)
A-Award
Simpson Curran
Chief Executive Officer
CEO / President 233 651
Value: $3.31M
Jan 06, 2026
Buy
Common Stock
A-Award
Simpson Curran
Chief Executive Officer
CEO / President 144 864
Value: $2.05M
Jan 06, 2026
Buy
Stock Options (Right to buy)
A-Award
Malzahn Craig
Chief Technology Officer
Officer 35 402
Value: $502.0K
Jan 06, 2026
Buy
Common Stock
A-Award
Malzahn Craig
Chief Technology Officer
Officer 65 847
Value: $933.7K
Jan 06, 2026
Buy
Stock Options (Right to buy)
A-Award
Pakola Steve
Chief Medical Officer
Officer 35 402
Value: $502.0K
Jan 06, 2026
Buy
Common Stock
A-Award
Pakola Steve
Chief Medical Officer
Officer 65 847
Value: $933.7K
Jan 06, 2026
Buy
Stock Options (Right to buy)
A-Award
Chan Mitchell
Chief Financial Officer
C-Suite Officer 39 650
Value: $562.2K
Jan 06, 2026
Buy
Common Stock
A-Award
Chan Mitchell
Chief Financial Officer
C-Suite Officer 73 749
Value: $1.05M
Jan 02, 2026
Sell
Common Stock
F-InKind
Pakola Steve
Chief Medical Officer
Officer 18 247
Value: $262.8K
Jan 02, 2026
Sell
Common Stock
F-InKind
Christmas Patrick J.
Chief Strategy & Legal Officer
Officer 9 793
Value: $141.0K
Jan 02, 2026
Sell
Common Stock
F-InKind
Malzahn Craig
Chief Technology Officer
Officer 1 238
Value: $17.8K
Jan 02, 2026
Sell
Common Stock
F-InKind
Simpson Curran
Chief Executive Officer
CEO / President 18 559
Value: $267.2K
Oct 09, 2025
Sell
Common Stock
S-Sale
Simpson Curran
Chief Executive Officer
CEO / President 20 811
Value: $262.6K
Oct 09, 2025
Sell
Common Stock
S-Sale
Simpson Curran
Chief Executive Officer
CEO / President 20 811
Value: $262.6K
Sep 29, 2025
Sell
Common Stock
S-Sale
Simpson Curran
Chief Executive Officer
CEO / President 7 624
Value: $76.5K
Sep 29, 2025
Sell
Common Stock
S-Sale
Simpson Curran
Chief Executive Officer
CEO / President 7 624
Value: $76.5K
Sep 10, 2025
Sell
Common Stock
S-Sale
Simpson Curran
Chief Executive Officer
CEO / President 7 734
Value: $77.5K
Sep 10, 2025
Sell
Common Stock
S-Sale
Simpson Curran
Chief Executive Officer
CEO / President 7 734
Value: $77.5K
Sep 01, 2025
Sell
Common Stock
F-InKind
Malzahn Craig
Chief Technology Officer
Officer 234
Value: $2K
Sep 01, 2025
Sell
Common Stock
F-InKind
Chan Mitchell
Chief Financial Officer
C-Suite Officer 4 901
Value: $43.8K
Sep 01, 2025
Sell
Common Stock
F-InKind
Chan Mitchell
Chief Financial Officer
C-Suite Officer 4 901
Value: $43.8K
Sep 01, 2025
Sell
Common Stock
F-InKind
Malzahn Craig
Chief Technology Officer
Officer 234
Value: $2K
Aug 01, 2025
Sell
Common Stock
F-InKind
Christmas Patrick J.
Chief Strategy & Legal Officer
Officer 4 699
Value: $38.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT REGENXBIO INC.
REGENXBIO
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, wh...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE